You are here

  • Home
  • Online First
  • Response to: Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis” by Sparks et al

Citation Tools

Article menu
Download PDFPDF
Correspondence response
Response to: Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis” by Sparks et al

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Wallace ZS, Sparks JA, Robinson PC, et al
Response to: Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis” by Sparks et al
Annals of the Rheumatic Diseases Published Online First: 23 August 2021. doi: 10.1136/annrheumdis-2021-220960